BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization: BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON (EIN 91-0653422)
Tax period: 2018-01-01 to 2018-12-31
Filed: 2019-11-12
IRS object ID: 201933169349306238
Schema version: 2018v3.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule O
Schedule R
Affiliated Group Schedule

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2019-11-12T03:39:41-00:00	ReturnTs
Tax Period End	2018-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	1918 8th Avenue Suite 2900	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2018-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	910653422	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	Benaroya Research Institute at Virginia Mason	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	BENA	BusinessNameControlTxt
Phone	2063426500	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	Michael Labosier	PersonNm
Person Title	Chief Financial Officer	PersonTitleTxt
Signature	2019-11-08	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	Sue Robison	PreparerPersonNm
Phone	2069134000	PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	204.147.223.1	IPv4AddressTxt

Field	Value	IRS element (for citing)
IP	2019-11-12	IPDt
IP Tm	23:37:17	IPTm
IP Timezone	PS	IPTimezoneCd
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	3A8BCFA172999187EBBEF58FE652F98775CE2010	AtSubmissionCreationDeviceId
At Submission Filing Device Id	3A8BCFA172999187EBBEF58FE652F98775CE2010	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2018	TaxYr
Build TS	2020-03-31 21:24:44Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	Jane Buckner MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$67,982,426	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	benaroyaresearch.org	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1956	FormationYr
Legal Domicile State	WA	LegalDomicileStateCd
Activity Or Mission	To advance the science that will predict, prevent, reverse, and cure diseases of the immune system.	ActivityOrMissionDesc
Voting Members Governing Body	20	VotingMembersGoverningBodyCnt
Voting Members Independent	15	VotingMembersIndependentCnt
Total Employee	329	TotalEmployeeCnt
Total Volunteers	5	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$175,948	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$60,243,416	PYContributionsGrantsAmt
CY Contributions Grants	$59,023,034	CYContributionsGrantsAmt
PY Program Service Revenue	$6,781,431	PYProgramServiceRevenueAmt
CY Program Service Revenue	$8,229,643	CYProgramServiceRevenueAmt
PY Investment Income	$456,650	PYInvestmentIncomeAmt
CY Investment Income	$191,489	CYInvestmentIncomeAmt
PY Other Revenue	$347,680	PYOtherRevenueAmt
CY Other Revenue	$347,680	CYOtherRevenueAmt
PY Total Revenue	$67,829,177	PYTotalRevenueAmt
CY Total Revenue	$67,791,846	CYTotalRevenueAmt
PY Grants And Similar Paid	$27,587,861	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$22,634,522	CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$25,600,727	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$26,095,485	CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$0	CYTotalFundraisingExpenseAmt
PY Other Expenses	$18,423,765	PYOtherExpensesAmt
CY Other Expenses	$18,050,564	CYOtherExpensesAmt
PY Total Expenses	$71,612,353	PYTotalExpensesAmt
CY Total Expenses	$66,780,571	CYTotalExpensesAmt
PY Revenues Less Expenses	-$3,783,176	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$1,011,275	CYRevenuesLessExpensesAmt
Total Assets BOY	$90,102,675	TotalAssetsBOYAmt
Total Assets EOY	$84,112,856	TotalAssetsEOYAmt
Total Liabilities BOY	$44,389,195	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$39,800,841	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$45,713,480	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$44,312,015	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	Advancing the science that will predict, prevent, reverse, and cure diseases of the immune system such as autoimmune disease, allergy, and asthma.	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$28,716,066	ExpenseAmt
Grant	$20,572,090	GrantAmt
Desc	Immune Tolerance Network Program. See Schedule O.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$7,982,351	ExpenseAmt
Grant	$1,239,582	GrantAmt
Desc	Immunology Program. See Schedule O.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$6,761,683	ExpenseAmt
Grant	$449,274	GrantAmt
Desc	Translational Program. See Schedule O.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$12,330,917	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$373,576	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$8,229,643	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$55,791,017	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	Yes (true)	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	false	ReportOtherLiabilitiesInd
Include FIN48 Footnote	false	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (true)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	false	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	Yes (true)	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	false	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	false	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	104	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	329	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	false	QuidProQuoContributionsInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	false	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	20	GoverningBodyVotingMembersCnt
Independent Voting Member	15	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (true)	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (true)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	Michael Labosier CFO	PersonNm
Phone	2063426505	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 Ninth Avenue	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
Jane Buckner MD
Ex Officio, President	040.00	Yes (X)	Yes (X)	$389,313	$0	$25,436
Carla Greenbaum MD
Director	040.00	Yes (X)		$231,304	$0	$30,688
Joyce Lammert MD PhD
Director	001.00	Yes (X)		$0	$648,231	$26,064	050.00
John Corman MD
Director	001.00	Yes (X)		$0	$710,194	$48,482	050.00
Gary Kaplan MD
Director	001.00	Yes (X)		$0	$1,455,167	$56,110	054.00
Rebecca Campbell
Director	001.00	Yes (X)		$0	$0	$0
Tom Cohen
Director	001.00	Yes (X)		$0	$0	$0
Carla DewBerry
Director, Chair	001.00	Yes (X)	Yes (X)	$0	$0	$0
Frank Dvorak PhD
Director, Vice-Chair	001.00	Yes (X)	Yes (X)	$0	$0	$0
Michael Gallatin
Director	001.00	Yes (X)		$0	$0	$0
Paul Hughes
Director	001.00	Yes (X)		$0	$0	$0
Nabil Istafanous
Director	001.00	Yes (X)		$0	$0	$0
Margaret Morrow
Director	001.00	Yes (X)		$0	$0	$0
Ben Reiber
Director	001.00	Yes (X)		$0	$0	$0
Proctor Shenk
Director	001.00	Yes (X)		$0	$0	$0
Diane St John
Director, Secretary	001.00	Yes (X)	Yes (X)	$0	$0	$0
David Williams
Director	001.00	Yes (X)		$0	$0	$0	004.00
Christopher Wilson MD
Director	001.00	Yes (X)		$0	$0	$0
Jeffrey S Wortley
Director, Treasurer	001.00	Yes (X)	Yes (X)	$0	$0	$0
Catherine Zimmerman
Director	001.00	Yes (X)		$0	$0	$0
Homer Lane Jr
Executive Director and Chief Financial Officer	040.00		Yes (X)	$309,314	$0	$34,906
Gerald Nepom MD PhD
Program Director, ITN	024.00			$153,753	$0	$27,192		Yes (X)
William Kwok PhD
Research Member	040.00			$236,141	$0	$27,836			Yes (X)
Steven Ziegler PhD
Director of Academic Affairs	040.00			$227,763	$0	$25,118			Yes (X)
James Lord PhD
Research Member	040.00			$188,133	$0	$22,110			Yes (X)
Margaret McCormick
Chief Administrative Officer	040.00			$185,583	$0	$0			Yes (X)
Lynn Rose
Director Scientific Administration	040.00			$178,676	$0	$25,105			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$2,099,980	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$2,813,592	TotReportableCompRltdOrgAmt
Total Other Compensation	$349,047	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	49	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1918 Eighth Ave Suite 2900	AddressLine1Txt
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd
ZIP	98101	ZIPCd

Field	Value	IRS element (for citing)
Services	Auditing Consulting	ServicesDesc
Compensation	$119,579	CompensationAmt

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	1	CntrctRcvdGreaterThan100KCnt
Related Organizations	$3,000,000	RelatedOrganizationsAmt
Government Grants	$45,278,726	GovernmentGrantsAmt
All Other Contributions	$10,744,308	AllOtherContributionsAmt
Total Contributions	$59,023,034	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
Commercial Studies	621500	$4,205,104	$4,205,104
Collaborative Research Core Service	621500	$4,024,539	$4,024,539

Field	Value	IRS element (for citing)
Total Program Service Revenue	$8,229,643	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$191,489	TotalRevenueColumnAmt
Exclusion	$191,489	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$538,260	RealAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$190,580	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$347,680	RealAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$347,680	TotalRevenueColumnAmt
Exclusion	$347,680	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$67,791,846	TotalRevenueColumnAmt
Related Or Exempt Func Income	$8,229,643	RelatedOrExemptFuncIncomeAmt
Exclusion	$539,169	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$21,193,686	TotalAmt
Program Services	$21,193,686	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$1,440,836	TotalAmt
Program Services	$1,440,836	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$1,093,606	TotalAmt
Program Services	$612,082	ProgramServicesAmt
Management And General	$481,524	ManagementAndGeneralAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$19,769,357	TotalAmt
Program Services	$14,397,070	ProgramServicesAmt
Management And General	$5,372,287	ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,637,028	TotalAmt
Program Services	$1,157,162	ProgramServicesAmt
Management And General	$479,866	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$2,135,956	TotalAmt
Program Services	$1,509,839	ProgramServicesAmt
Management And General	$626,117	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$1,459,538	TotalAmt
Program Services	$1,031,700	ProgramServicesAmt
Management And General	$427,838	ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$18,412	TotalAmt
Management And General	$18,412	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$119,579	TotalAmt
Management And General	$119,579	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Fees For Services Prof Fundraising		FeesForServicesProfFundraising

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$2,018,346	TotalAmt
Program Services	$1,347,163	ProgramServicesAmt
Management And General	$671,183	ManagementAndGeneralAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$46,839	TotalAmt
Program Services	$38	ProgramServicesAmt
Management And General	$46,801	ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$155,551	TotalAmt
Program Services	$40,672	ProgramServicesAmt
Management And General	$114,879	ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,419,642	TotalAmt
Program Services	$701,086	ProgramServicesAmt
Management And General	$718,556	ManagementAndGeneralAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$2,813,365	TotalAmt
Program Services	$2,380,567	ProgramServicesAmt
Management And General	$432,798	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$309,419	TotalAmt
Program Services	$271,114	ProgramServicesAmt
Management And General	$38,305	ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$83,638	TotalAmt
Program Services	$62,822	ProgramServicesAmt
Management And General	$20,816	ManagementAndGeneralAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$605,267	TotalAmt
Program Services	$526,582	ProgramServicesAmt
Management And General	$78,685	ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$3,653,748	TotalAmt
Program Services	$2,884,897	ProgramServicesAmt
Management And General	$768,851	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$50,506	TotalAmt
Program Services	$30	ProgramServicesAmt
Management And General	$50,476	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt
Supplies and Miscellaneous Expenses	$4,381,748	$4,241,266	$140,482
Other Purchased Services	$418,418	$252,179	$166,239
Patient Costs	$1,120,222	$1,120,215	$7
Research Participants Expenses	$373,386	$371,273	$2,113

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$462,478	TotalAmt
Program Services	$248,738	ProgramServicesAmt
Management And General	$213,740	ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$66,780,571	TotalAmt
Program Services	$55,791,017	ProgramServicesAmt
Management And General	$10,989,554	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$6,125,815	BOYAmt
EOY	$5,711,406	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$363,312	BOYAmt
EOY	$576,745	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$13,584,865	BOYAmt
EOY	$11,995,906	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$1,647,502	BOYAmt
EOY	$1,591,784	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$400,177	BOYAmt
EOY	$509,432	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$73,401,017	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$48,486,896	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$27,235,510	BOYAmt
EOY	$24,914,121	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$12,181,585	BOYAmt
EOY	$12,066,383	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$27,320,900	BOYAmt
EOY	$25,745,020	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$1,243,009	BOYAmt
EOY	$1,002,059	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$90,102,675	BOYAmt
EOY	$84,112,856	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$11,146,141	BOYAmt
EOY	$9,535,580	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$6,511,564	BOYAmt
EOY	$4,548,771	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$26,731,490	BOYAmt
EOY	$25,716,490	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$44,389,195	BOYAmt
EOY	$39,800,841	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$18,078,247	BOYAmt
EOY	$17,232,381	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$13,575,861	BOYAmt
EOY	$12,465,089	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$14,059,372	BOYAmt
EOY	$14,614,545	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$45,713,480	BOYAmt
EOY	$44,312,015	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$90,102,675	BOYAmt
EOY	$84,112,856	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$1,011,275	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$2,412,740	NetUnrlzdGainsLossesInvstAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Medical Research Organization	Yes (X)	MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp

Supported Organization Name SupportedOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	Virginia Mason Medical Center	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
City	Seattle	CityNm
State Abbreviation	WA	StateAbbreviationCd

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$54,174,085	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$59,709,893	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$71,346,495	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$60,243,416	CurrentTaxYearMinus1YearAmt
Current Tax Year	$59,023,034	CurrentTaxYearAmt
Total	$304,496,923	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$54,174,085	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$59,709,893	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$71,346,495	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$60,243,416	CurrentTaxYearMinus1YearAmt
Current Tax Year	$59,023,034	CurrentTaxYearAmt
Total	$304,496,923	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$29,172,644	SubstantialContributorsTotAmt
Public Support Total170	$275,324,279	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$707,157	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$430,555	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$933,027	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$994,910	CurrentTaxYearMinus1YearAmt
Current Tax Year	$729,749	CurrentTaxYearAmt
Total	$3,795,398	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$6,639,555	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$7,021,290	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$8,553,010	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$6,781,431	CurrentTaxYearMinus1YearAmt
Current Tax Year	$8,229,643	CurrentTaxYearAmt
Total	$37,224,929	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$345,517,250	TotalSupportAmt
Public Support CY170	0.79680	PublicSupportCY170Pct
Public Support PY170	0.79860	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind
Public Support CY509	0.00000	PublicSupportCY509Pct
Investment Income CY	0.00000	InvestmentIncomeCYPct
Facts And Circumstances Test	Part II Section B Line 10 2018 Other Income of 8,229,643 is comprised of 4,205,104 of Clinical Research Program revenue, 3,447,597 of Collaborative Research Agreement projects, 545,781 of External Core Income, and 31,161 of miscellaneous income.	FactsAndCircumstancesTestTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Organization Belongs Afflt Grp	Yes (X)	OrganizationBelongsAffltGrpInd

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$180,464	AffiliatedGroupTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$113,574	AffiliatedGroupTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Affiliated Group Total	$294,038	AffiliatedGroupTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$66,780,571	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,685,581,835	AffiliatedGroupTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$66,780,571	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,685,875,873	AffiliatedGroupTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt
Affiliated Group Total	$1,000,000	AffiliatedGroupTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt
Affiliated Group Total	$250,000	AffiliatedGroupTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$154,766	CurrentYearMinus3Amt
Current Year Minus2	$275,782	CurrentYearMinus2Amt
Current Year Minus1	$284,247	CurrentYearMinus1Amt
Current Year	$294,038	CurrentYearAmt
Total	$1,008,833	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$108,173	CurrentYearMinus3Amt
Current Year Minus2	$163,134	CurrentYearMinus2Amt
Current Year Minus1	$175,480	CurrentYearMinus1Amt
Current Year	$180,464	CurrentYearAmt
Total	$627,251	TotalAmt

Field	Value	IRS element (for citing)
Volunteers	false	VolunteersInd
Paid Staff Or Management	false	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Mailings Members	false	MailingsMembersInd
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Grants Other Organizations	false	GrantsOtherOrganizationsInd
Direct Contact Legislators	false	DirectContactLegislatorsInd
Rallies Demonstrations	false	RalliesDemonstrationsInd
Other Activities	false	OtherActivitiesInd
Not Described Section501c3	false	NotDescribedSection501c3Ind
Form4720 Filed4912 Tax	false	Form4720Filed4912TaxInd

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
II-A A	Benaroya Research Institute at Virginia Mason, EIN 91-0653422, 1201 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0.
II-A A continued	Virginia Mason Health System, EIN 91-1351110, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0
II-A A continued	Virginia Mason Institute, EIN 26-3763656, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures, 0 Excess Lobbying Expenditures.
II-A A continued	Virginia Mason Medical Center, EIN 91-0565539, 1100 Ninth Avenue, Seattle, WA 98101. Electing member. Grassroots Lobbying Expenditures 133, 835 Direct Lobbying Expenditures 53,574. Excess Lobbying Expenditures 0. Tax year ending December 31, 1998 was the first year in which Virginia Mason Medical Center made the election under Section 501h. The election was not revoked before the start of the tax year ending December 31, 2018.
II-A A continued	Yakima Valley Memorial Hospital Association, EIN 91-0567263, 2811 Tieton Drive, Yakima, WA 98902. Non-electing member. 46,629 Grassroots Lobbying Expenditures 60,000 Direct Lobbying Expenditures. Excess Lobbying Expenditures 0.

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Incl Escrow Custodial Acct Liab	false	InclEscrowCustodialAcctLiabInd
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	Yes (true)	EndowmentsHeldRelatedOrgInd
Related Org List Sch R	Yes (true)	RelatedOrgListSchRInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$756,906	OtherCostOrOtherBasisAmt
Book Value	$756,906	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$49,563,103	OtherCostOrOtherBasisAmt
Depreciation	$28,751,108	DepreciationAmt
Book Value	$20,811,995	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$215,595	OtherCostOrOtherBasisAmt
Depreciation	$197,799	DepreciationAmt
Book Value	$17,796	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$22,340,094	OtherCostOrOtherBasisAmt
Depreciation	$19,537,989	DepreciationAmt
Book Value	$2,802,105	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$525,319	OtherCostOrOtherBasisAmt
Book Value	$525,319	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$24,914,121	TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (3 entries)

DescDesc	Book ValueBookValueAmt	Method ValuationMethodValuationCd
Financial derivatives and other financial products
Closely-held equity interests
Interest in Net Assets of Virginia Mason Health System	$25,745,020	F

Field	Value	IRS element (for citing)
Total Book Value Securities	$25,745,020	TotalBookValueSecuritiesAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	Federal income taxes	Desc

Field	Value	IRS element (for citing)
Total Rev Etc Audited Fincl Stmt	$65,379,106	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$2,412,740	NetUnrealizedGainsInvstAmt
Revenue Not Reported	-$2,412,740	RevenueNotReportedAmt
Revenue Subtotal	$67,791,846	RevenueSubtotalAmt
Total Revenue Per Form990	$67,791,846	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$66,780,571	TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal	$66,780,571	ExpensesSubtotalAmt
Total Expenses Per Form990	$66,780,571	TotalExpensesPerForm990Amt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
Europe Including Iceland and Greenland	Conferences	Medical Research	$40,987
East Asia and the Pacific	Conferences	Medical Research	$1,492
North America	Conferences	Medical Research	$940
Europe Including Iceland and Greenland	Grant	Medical Research	$1,091,093
East Asia and the Pacific	Grant	Medical Research	$324,472
North America	Grant	Medical Research	$25,271

Field	Value	IRS element (for citing)
Subtotal Spent	$1,484,255	SubtotalSpentAmt
Total Spent	$1,484,255	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (10 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
Europe Including Iceland and Greenland	Medical Research	$398,678	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$376,854	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$166,166	Wire Transfer
Europe Including Iceland and Greenland	Medical Research	$149,395	Wire Transfer
East Asia and the Pacific	Medical Research	$138,406	Wire Transfer
East Asia and the Pacific	Medical Research	$88,854	Wire Transfer
East Asia and the Pacific	Medical Research	$67,344	Wire Transfer
East Asia and the Pacific	Medical Research	$29,868	Wire Transfer
North America	Medical Research	$12,707	Wire Transfer.
North America	Medical Research	$12,564	Wire Transfer

Field	Value	IRS element (for citing)
Total Other Org	10	TotalOtherOrgCnt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 2	Sub-recipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing federal grants. The Sub-recipient Monitoring Policy provides assurance that sub-recipients comply with federal grant regulations. This policy sets the criteria to establish eligibility of sub-recipients to provide annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessment of sub-recipient internal controls and a standardized risk assessment is presented to management on each sub-recipient. A Management Letter is issued to each sub-recipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring sub-recipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated.
Part I Line 3f	The expenditures were actual expenses incurred in the region based on individual expense reports and tracking of expenditures by grant or department on the accrual basis of accounting.
Part II Line 1	The expenditures were expenses incurred in the region based on award goals on the accrual basis of accounting.

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (66 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
Ann&Robert H Lurie Children's Hospital of Chicago
225 East Chicago Ave No 205	Chicago	IL	606112991	362170833	501c3	$23,919	Medical Research
Arkansas Children's Hospital Research Institute
One Childrens Way	Little Rock	AR	722023591	710694931	501c3	$56,884	Medical Research
Asthma Inc
9725 3rd Ave NE	Seattle	WA	98115	237219813	501c3	$27,685	Medical Research
Regents of the University of Colorado
Barbara Davis Center	Aurora	CO	80045	846000555	501c3	$19,546	Medical Research
Baylor Research Institute
3301 Live Oak	Dallas	TX	75204	751921898	501c3	$9,468	Medical Research
Boston University
25 Buick Street Suite 200	Boston	MA	02215	042103547	501c3	$22,524	Medical Research
Brigham And Women's Hospital
Bank of America NA	Boston	MA	022413887	042312909	501c3	$16,723	Medical Research
Case Western Reserve University
10900 Euclid Avenue	Cleveland	OH	441067037	341018992	501c3	$16,496	Medical Research
Children's Hosp of Philadelphia
PO Box 8550	Philadelphia	PA	191781457	231352166	501c3	$79,823	Medical Research
Children's Mercy Hospital
2401 Gillham Road	Kansas City	MO	64101	440605373	501c3	$62,426	Medical Research
The Cleveland Clinic Foundation
9500 Euclid Avenue JJN5-001	Cleveland	OH	44195	340714585	501c3	$46,478	Medical Research
Columbia University Trustees of
PO Box 29789	New York	NY	100879789	135598093	501c3	$89,803	Medical Research
Dana-Farber Cancer Institute Inc
450 Brookline Ave 431C	Boston	MA	02215	042263040	501c3	$288,099	Medical Research
Denver Nephrologists PC
130 Rampart Way Suite 300B	Denver	CO	80230	840591433		$17,583	Medical Research
Dermatology Research Assoc Inc
8930 S Sepulveda Blvd Ste 114	Los Angeles	CA	90045	273947370		$14,114	Medical Research
Duke University
PO Box 602651	Charlotte	NC	282602651	560532129	501c3	$392,135	Medical Research
Emory University
PO Box 935084	Atlanta	GA	311935084	580566256	501c3	$125,560	Medical Research
Feinstein Institute for Medical Research
350 Community Drive	Manhasset	NY	11030	112673595	501c3	$9,819	Medical Research
Fred Hutchinson Cancer Research Center
PO Box 19024	Seattle	WA	98109	237156071	501c3	$93,900	Medical Research
Georgetown University
2121 Wisconsin Ave NW	Washington	DC	20007	530196603	501c3	$19,774	Medical Research
Icahn School of Medicine at Mount Sinai
One Gustave L Levy Place Box 3500	New York	NY	100296574	136171197	501c3	$531,892	Medical Research
Indiana University
Dept 78867	Detroit	MI	482780867	356001673	501c3	$194,353	Medical Research
Johns Hopkins University
Central Lockbox co B of A	Chicago	IL	60693	520595110	501c3	$437,963	Medical Research
Jonathan Corren MD Inc
10780 Santa Monica Blvd 280	Los Angeles	CA	90025	462346264		$69,580	Medical Research
Joslin Diabetes Center
One Joslin Place	Boston	MA	022155306	042203836	501c3	$166,926	Medical Research
Massachusetts General Hospital
PO Box 3829	Boston	MA	022413829	042697983	501c3	$5,825,904	Medical Research
Medical University of South Carolina
19 Hagood Avenue Ste 604	Charleston	SC	29425	576000722	South Carolina	$26,593	Medical Research
National Jewish Health
1400 Jackson Street M213	Denver	CO	80206	742044647	501c3	$11,630	Medical Research
New York University-School of Medicine
PO Box 415026	Boston	MA	022415026	135562308	501c3	$5,140	Medical Research
Northwestern University
633 Clark Room G547	Evanston	IL	60208	362167817	501c3	$143,741	Medical Research
Ohio State University
Office of Sponsored Programs	Columbus	OH	43210	316025986	501c3	$13,663	Medical Research
Oklahoma Medical Research Foundation
825 NE 13th Street	Oklahoma City	OK	73104	730580274	501c3	$49,310	Medical Research
Polyclinic
Madison Center 904 7th Ave	Seattle	WA	98104	910369070	501c3	$39,076	Medical Research
Research Foundation State University of New York
PO Box 9	Albany	NY	122010009	141368361	501c3	$33,951	Medical Research
Rockefeller University
1230 York Ave	New York	NY	100656307	131624158	501c3	$58,559	Medical Research
Rutgers the State University of New Jersey
Office of Research and Sponsored Pr	New Brunswick	NJ	089018559	226001086	501c3	$351,310	Medical Research
Sanford Research
2301 E 60th St N	Sioux Falls	SD	57104	460450378	501c3	$153,414	Medical Research
Seattle Childrens Hospital
PO Box 24728	Seattle	WA	981240728	910564748	501c3	$471,632	Medical Research
Stanford University
PO Box 44253	San Francisco	CA	941444253	941156365	501c3	$394,510	Medical Research
State University of Iowa
118 S Clinton St - SCST	Iowa City	IA	52242	426004813	Iowa	$91,733	Medical Research
St Jude Children's Research Hospital Inc
PO Box 1000 Dept 949	Memphis	TN	381480949	620646012	501c3	$280,794	Medical Research
Tulane University
1430 Tulane Ave Dermatology 8036	New Orleans	LA	70112	720423889	501c3	$15,653	Medical Research
Unitversity of Washington Grants
4333 Brooklyn Ave NE	Seattle	WA	98195	916001537	Washington	$666,763	Medical Research
Univ of Minnesota Regents
NW 5957	Minneapollis	MN	554855957	416007513	Minnesota	$103,635	Medical Research
Univ of Texas SW Med Ctr
Grants Management	Dallas	TX	752841753	756002868	Texas	$85,417	Medical Research
University of Colorado-Denver
PO Box 910238	Denver	CO	802910238	846000555	501c3	$349,778	Medical Research
University of Pennsylvania
PO Box 785541	Philadelphia	PA	171785541	231352685	501c3	$148,795	Medical Research
University of Florida Board of Trustees
PO Box 113001	Gainesville	FL	32611	596002052	501c3	$22,020	Medical Research
University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard	Dallas	TX	75390	756002868	501c3	$7,977	Medical Research
University of Nebraska Medical Center
985045 Nebraska Medical Center	Omaha	NE	681985045	470049123	501c3	$33,458	Medical Research
University of Michigan
Box 223131	Pittsburgh	PA	152512131	386006309	501c3	$87,206	Medical Research
University of North Carolina at Chapel Hill
PO Box 402420	Atlanta	GA	303842240	566001393	501c3	$245,134	Medical Research
University of Utah
Grants and Contract Accounting	Salt Lake City	UT	84132	876000525	501c3	$14,726	Medical Research
University of Massachusetts Worcester
55 Lake Avenue North	Worchester	MA	016550002	043167352	501c3	$54,605	Medical Research
University of Chicago
5841 S Maryland Ave	Chicago	IL	60637	362177139	501c3	$28,577	Medical Research
University of California San Francisco
Controllers Office	San Francisco	CA	941430897	946036493	501c3	$7,721,453	Medical Research
University of Pittsburgh
Research Cost Accounting	Pittsburgh	PA	152517220	250965591	501c3	$326,822	Medical Research
University of Michigan Regents of the
Box 223131	Pittsburgh	PA	152512131	386006309	501c3	$16,084	Medical Research
University of Miami
1320 S Dixie Highway	Coral Gables	FL	331462926	590624458	501c3	$12,968	Medical Research
University of California Los Angeles
11000 Kinross Ave Ste 211	Los Angeles	CA	90095	956006143	501c3	$42,724	Medical Research
University of Wisconsin Board of Regents
600 Highland Ave Madison WI 53792	Madison	WI	53792	396006492	501c3	$29,550	Medical Research
University of Texas Health Science Center Houston
7000 Fannin St	Houston	TX	770305400	741761309	Texas	$39,699	Medical Research
Vanderbilt University
Department of Finance	Dallas	TX	753121236	620476822	501c3	$170,809	Medical Research
Vital Prospects Clinical Research Institute PC
7307 S Yale Ave Suite 200	Tulsa	OK	74136	261814411		$13,724	Medical Research
Wake Forest University Health Sciences
Medical Center Boulevard	WinstonSalem	NC	27157	223849199	501c3	$13,504	Medical Research
Yale University
Grant and Contract Financial Admini	New Haven	CT	065081873	080648973	501c3	$201,707	Medical Research

Field	Value	IRS element (for citing)
Total501c3 Org	62	Total501c3OrgCnt
Total Other Org	4	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Part I Line 2	FormAndLineReferenceDesc
Explanation	Sub-recipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing federal grants. The Sub-recipient Monitoring Policy provides assurance that sub-recipients comply with federal grant regulations. This policy sets the criteria to establish eligibility of sub-recipients to provide annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessment of sub-recipient internal controls and a standardized risk assessment is presented to management on each sub-recipient. A Management Letter is issued to each sub-recipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring sub-recipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	Yes (X)	FirstClassOrCharterTravelInd
Club Dues Or Fees	Yes (X)	ClubDuesOrFeesInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (true)	SubstantiationRequiredInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	false	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	false	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt
Jane Buckner MD
Ex Officio, President	$342,329	$46,984	$24,500	$936	$414,749
Carla Greenbaum MD
Director	$231,304		$24,500	$6,188	$261,992
Joyce Lammert MD PhD
Director						$481,542	$73,657	$93,032	$14,350	$11,714	$674,295
John Corman MD
Director						$600,505	$90,775	$18,914	$26,467	$22,015	$758,676
Gary Kaplan MD
Director						$1,150,154	$283,313	$21,700	$14,350	$41,760	$1,511,277
Homer Lane Jr
Executive Director and Chief Financial Officer	$269,715	$39,599	$24,500	$10,406	$344,220
Gerald Nepom MD PhD
Program Director, ITN	$153,753		$24,000	$3,192	$180,945
William Kwok PhD
Research Member	$236,141		$24,500	$3,336	$263,977
Steven Ziegler PhD
Director of Academic Affairs	$227,763		$17,330	$7,788	$252,881
James Lord PhD
Research Member	$188,133		$17,634	$4,476	$210,243
Margaret McCormick
Chief Administrative Officer	$185,583				$185,583
Lynn Rose
Director Scientific Administration	$178,676		$18,389	$6,716	$203,781

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line 1a	Social club dues are provided to two members of the senior leadership team who use the club memberships for business purposes. These payments are treated as non-taxable.
Part I Line 3	Benaroya Research Institute at Virginia Mason BRI delegates to Virginia Mason Health Systems its parent and sole member Board Compensation and Benefits Committee, a committee composed of independent Health System Board members to whom the BRI Board has delegated the authority to approve all compensation and benefits for the executive leaders of BRI. To ensure that such benefit plans are market competitive and reasonable, the Committee receives support and advice, including appropriate market comparability data from an independent compensation consultant with expertise in the health care industry and access to relevant market data. See Schedule O for additional disclosure.
Part I Line 4b	The Virginia Mason Medical Center has a Supplemental Executive Retirement Plan SERP in which certain BRI Executives participate. The SERP is a 457 f nonqualified deferred compensation plan pursuant to which plan benefits are subject to a substantial risk of forfeiture, entered into in connection with certain senior executives joining the Medical Center. The plan was approved by the Boards Compensation and Benefits Committee, a committee composed of independent board members to whom the Board delegates the authority to approve compensation and benefits to the Medical Centers most senior executives. The Committee receives advice from an independent compensation consultant to ensure that compensation and benefits, including the SERP, are market competitive and reasonable. Supplemental Executive Retirement Plans such as this are customary for senior executives in the health care industry.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (2 entries)

Bond ReferenceBondReferenceCd	Bond Issuer EINBondIssuerEIN	CUSIPCUSIPNum	Bond IssuedBondIssuedDt	Issue PriceIssuePriceAmt	PurposePurposeDesc	DefeasedDefeasedInd	On Behalf Of IssuerOnBehalfOfIssuerInd	Pool FinancingPoolFinancingInd
WA Econ Devel Fin Auth-2012 Series B
A	911493002	000000000	2012-06-01	$10,390,000	See Part VI	false	Yes (true)	false
WA Econ Devel Fin Auth-Series 2016
B	911493002	000000000	2016-06-01	$18,631,490	See Part VI	false	Yes (true)	false

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (2 entries)

Bond ReferenceBondReferenceCd	RetiredRetiredAmt	Total ProceedsTotalProceedsAmt	Capital ExpendituresCapitalExpendituresAmt	Other Spent ProceedsOtherSpentProceedsAmt	Substantial CompletionSubstantialCompletionYr	Refunding Tax Exempt BondsRefundingTaxExemptBondsInd	Refunding Taxable BondsRefundingTaxableBondsInd	Final Allocation MadeFinalAllocationMadeInd	Adequate Books And Rec MaintAdequateBooksAndRecMaintInd
A	$1,995,000	$10,390,348	$2,550,348	$7,840,000	2013	Yes (true)	false	Yes (true)	Yes (true)
B	$1,310,000	$18,631,490		$18,631,490		Yes (true)	false	Yes (true)	Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (2 entries)

Bond ReferenceBondReferenceCd	Owning Bond Financed PropertyOwningBondFinancedPropertyInd	Any Lease ArrangementsAnyLeaseArrangementsInd	Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd	Any Research AgreementsAnyResearchAgreementsInd	Engage Bond Counsel ResearchEngageBondCounselResearchInd	Private Bus Use By OthersPrivateBusUseByOthersPct	Total Private Business UseTotalPrivateBusinessUsePct	Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd	Change In Use Bond Financed PropChangeInUseBondFinancedPropInd	Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
A	false	Yes (true)	false	Yes (true)	Yes (true)	0.02030	0.02030	false	false	Yes (true)
B	false	Yes (true)	false	Yes (true)	Yes (true)	0.02030	0.02030	false	false	Yes (true)

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (2 entries)

Bond ReferenceBondReferenceCd	Form8038 T FiledForm8038TFiledInd	Rebate Not Due YetRebateNotDueYetInd	Variable Rate IssueVariableRateIssueInd	Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd	Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd	Gross Proceeds InvestedGrossProceedsInvestedInd	Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd
A	false	Yes (true)	false	false	false	false	Yes (true)
B	false	Yes (true)	false	false	false	false	Yes (true)

Procedures Corrective Action ProceduresCorrectiveActionGrp (2 entries)

Bond ReferenceBondReferenceCd	Procedures Corrective ActionProceduresCorrectiveActionInd
A	Yes (true)
B	Yes (true)

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Part I Line A	Column F. Purposes to currently refund WEDFA Series 2006C bonds issued 11/15/2006, and to fund research facility improvements.
Part I Line B	Column F. Purposes to currently refund WEDFA Series 2012A taxable bonds issued 06/01/2012. No tax-exempt private activity bonds are being refunded.
Part I Line A, B	Difference between Part I, column e and Part II, Line 3 is investment earnings.
Line B	Difference between Part I, column e and Part II, Line 3 is investment earnings.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (13 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part III, Line 1	Benaroya Research Institute at Virginia Mason BRI is a world-renowned, non-profit research institute committed to advancing the science that will predict, prevent, reverse and cure diseases of the immune system. BRI researchers uniquely study the immune system in both health and disease, with the ultimate goal of achieving a healthy immune system for each individual. Diseases we study include type 1 diabetes, rheumatoid arthritis, lupus, multiple sclerosis, Crohns and colitis as well as allergies and cancer. BRI accelerates discovery through laboratory breakthroughs in immunology that can be translated to clinical therapies. BRI is affiliated with the Virginia Mason Health System, which provides governance oversight and the Virginia Mason Foundation provides development support. In 2018, BRI scientists led four international centers for autoimmune disease research and collaborated with colleagues all over the world. These researchers generated 76 scientific publications that were published in prestigious research journals, delivered 82 presentations at domestic and international research conferences and received many grants. Nearly half of BRIs research faculty also serve as affiliate professors at the University of Washington and mentor postdoctoral fellows, graduate students and summer interns. Their leadership, expertise, collaboration, dedication and curiosity drive our pioneering discoveries. BRI is led by President Jane H. Buckner, MD, and Executive Director/COO Margaret McCormick, PhD. About the Diseases BRI Studies One in 15 Americans suffers from an autoimmune disease, and 25 of those have more than one. Even more Americans, about one in five, suffer from an allergy, which is an immune system related disease. A recent BRI discovery linked a protein found in asthma and other allergic disease to also be a key player in metastatic breast cancer. This illustrates how immune system diseases are connected and how research in one disease can have implications across many other diseases.
Form 990, Part III, Line 4	One unique quality of BRI is the close integration of three types of medical research - laboratory research, translational research and clinical research - to improve lives. Our scientists collaborate to explore the basic science issues as well as clinical applications, which is the best way to design studies with the highest potential for success. For BRI, discovery starts in the laboratory but is driven by patient issues addressed in the clinic. 2018 advancements of the Immune Tolerance Network and in BRIs immunology, translational and clinical research, among other areas are highlighted below.
Form 990, Part III, Line 4a	Funding for the Immune Tolerance Network ITN was awarded to BRIs Dr. Jerry Nepom in 2014 from the National Institute of Allergy and Infectious Disease NIAID of the National Institutes of Health NIH. The 7-year award, totaling 27 million annually supports the ITN, a research consortium established in 1999 with a primary focus on the development of new tolerogenic approaches for the treatment and prevention of disease in three clinical areas asthma and allergic diseases autoimmune diseases and immune-mediated rejection of transplanted solid organs, tissues and cells. As the Prime recipient of this grant, BRI is responsible for the management of the overall grant from NIAID including oversight of all aspects of the Networks infrastructure. The major activities in 2018 were diverse, but continued to center on preserving the ITNs cohesive project focused environment and its framework which has proven so successful in the management of a large cooperative agreement grant. Key outcomes in 2018 include the following 1 Cross Network Integration A top priority in this reporting period was to continue the successful ITN infrastructure which is spread across three main operational sites. This required careful planning and collaboration as the ITNs major centers of operations are geographically diverse, located in Seattle, San Francisco and Bethesda. Few changes were made to the existing network integration as the current model continues to successfully support the overall ITN program. Establishing new relationships and vital connections within the research community continued to be an ITN goal.
Form 990, Part III, Line 4a continued	Immunology Research Program advances include 1 Personalized Treatments for Peanut Allergy - BRI received a grant to accelerate discovery of treatments for peanut allergy through a collaboration involving three BRI labs, Virginia Mason physicians and sponsors of two clinical trials. This two-pronged study first researches peanut allergy patients immune responses and classifies them into subgroups. Secondly, researchers evaluate treatment options being used in a pair of clinical trials to determine how specific treatments can be matched to specific patients to teach their immune systems to tolerate peanut protein. 2 Uncovering a New Strategy for Stopping Breast Cancer - Scientists at BRI made a discovery that opens the door to a potentially game-changing way to stop breast cancer tumors from growing and spreading. The researchers pinpointed how a protein called thymic stromal lymphopoietin TSLP helps breast cancer tumors survive and grow. Even more significant, the researchers showed that blocking TSLP in model systems can significantly inhibit the growth of breast tumors and halt metastasis to the lungs. The study was published in Nature Immunology. 3 Discovering how Lupus is Triggered - Lupus is one of the most difficult autoimmune diseases to diagnose and treat. Clinicians and researchers at Virginia Mason and BRI made a new discovery regarding how lupus is triggered, and began to explore how the newly discovered mechanism works and how to affect it. The mechanism prevents the immune system from reacting to the debris that leaks from cells as they die. A new grant will allow the research team to understand how this mechanism works in a particular type of immune cell, the plasmacytoid dentdritic cell, which can serve as a master regulator of immune responses and has been heavily implicated as a major contributor to lupus and other autoimmune diseases.
Form 990, Part III, Line 4b	Translational research is a scientific approach that allows research observations made in the basic research lab to be quickly tested in the clinic with patients, and results brought back to the lab again in an expedient and systematic way. This research is translating new methods that improve our ability to predict disease risk, prevent onset of disease, decrease disease progression and make treatments safer and better. The research emphasis of the BRI Translational Research Program is in the areas of autoimmune and immune-mediated diseases. The BRI biorepository, or biobank, is a collection of blood, serum and tissue samples, as well as medical histories, from volunteers with and without autoimmune and immune system diseases. BRI scientists and physician collaborators work together to study the blood serum samples along with medical and demographic data collected from people with autoimmune and immune-mediated diseases. These include multiple sclerosis, type 1 diabetes, lupus, rheumatoid arthritis, inflammatory bowel disease, allergy and asthma. BRIs biorepository samples date back to 2000 and include multiple disease categories and a biorepository of healthy people for comparison purposes. Advancements in 2018 included the following 1 Autoimmune Disease Research in the Down Syndrome Population - BRI scientists were awarded a one-year grant to build a Down Syndrome DS biorepository to research the connection between autoimmune disease and DS. The grant will help fund a dedicated biorepository for people with DS with and without autoimmune diseases, who are willing to donate a blood sample and provide health information for scientific research. The DS population has been underrepresented in medical research, especially considering nearly 50 percent of this population have an autoimmune disease AID, among other immune system diseases.
Form 990, Part III, Line 4c	Type 1 diabetes is a focal point of research at BRI. As an international leader in type 1 diabetes research, starting with identification of a genetic marker over 30 years ago, BRI is dedicated to finding biomarkers and therapies that predict, prevent, reverse and ultimately eliminate this disease. Advancement in 2018 included the following 1 Discovery of a new type 1 diabetes attacker cell A team of researchers at BRI discovered that patients with type 1 diabetes have a unique set of T cells that have grown and multiplied, increasing the numbers of bad cells that can attack the pancreas. This information can be used to decode the bad cells and find out what makes them tick. These unique T cells are rare in healthy individuals, but exist in significantly higher numbers in patients with type 1 diabetes. These T cells are part of an army that attacks the insulin-producing cells in the pancreas, destroying them so they cant make insulin anymore. The team is now working to understand when these unique T cells appear. If they can be found before a patient develops symptoms of type 1 diabetes, the presence of these cells could be used to monitor disease progression or serve as a target for treatments to preserve the bodys ability to produce insulin. 2 Waking Up Beta Cells Study - BRI is leading the first study involving adults who have lived with T1D over the long-term, to see if a drug could kick start sleeping beta cells so they make full-fledged insulin. This study is only available at BRI and at another site in Idaho. BRI leads the Type 1 Diabetes TrialNet, an international network of leading academic institutions, physicians, scientists and healthcare teams dedicated to the prevention of type 1 diabetes. TrialNet offers risk screening for relatives of people with type 1 diabetes and innovative clinical studies to preserve insulin production. 3 The TrialNet Pathway to Prevention study - Now anyone who tests positive for two or more autoantibodies can be classified as having stage one T1D. This helps doctors know when patients are in the diseases pre-symptom stages, so they can plan treatment. Its how high blood pressure can predict heart attack and stroke. Today, we can treat high blood pressure long before someone experiences heart symptoms or complications. The same is becoming true for T1D. We can match people in stage one with clinical trials of therapies that try to prevent the disease or slow it down. Home to the JDRF Core for Clinical Assay Validation CAV, BRI plays an important role in identifying type 1 diabetes biomarkers and in helping outside researchers get the most accurate test results. The CAV is pinpointing key biomarkers, such as those indicating which patients will keep making insulin for years and which patients wont. The CAV also helps maintain quality control for a worldwide network of research labs by asking them to perform specific tests and reviewing their results.
Form 990, Part III, Line 4d	1 The Clinical Research Program at BRI oversees all clinical research at Virginia Mason Medical Center which uniquely combines the expertise of a world-renowned medical research institute with the remarkable care of a healthcare quality leader. The BRI Clinical Research Program supports Virginia Mason clinical investigators in studies across a wide variety of autoimmune and immune-mediated diseases and conditions, as well as a broad range of other diseases such as cancer and cardiac disease. Each year the Clinical Research Program staff annually enrolls approximately 1500 study participants into Virginia Mason trials. This program involves approximately 170 research investigators, oversees more than 500 active studies with more than 275 studies currently open to enrollment. 2 Evaluating Immune Responses to Gluten BRI scientists are studying the use of short-term gluten challenge in celiac disease as a model to assess antigen-specific immune responses in humans. In people with celiac disease, T cells in the intestine recognizing a protein found in gluten gliadin deamidated peptide are activated by antigen presenting cells after oral ingestion of gluten. The activation of these cells results in a series of cascading immune responses. To better understand the immune cells involved when the growth of cancer cells goes unchecked, immunologists at BRI, along with physicians at Virginia Mason, are involved in a research collaboration in which blood samples are taken from patients before and after receiving immune checkpoint inhibitors. A comparison of these blood samples enable the characterization of tumor-attacking immune cells and the search for associated biomarkers for cancer and response to therapy. 3 Testing a New MS Therapy - a new research study at BRI and Virginia Mason sought to find out if an experimental oral drug, similar to a currently available MS medication, would be just as effective as the current one, but with fewer gastrointestinal side effects. In the initial study, half the research participants took this experimental drug and half took the current drug. Participants who finished the five-week study could then enroll in a two-year study of the experimental drug, currently under way.
Form 990, Part VI, Section A, Line 1a	The governing body delegates to an Executive Committee comprised of four officers of the Board and the Chairs of each standing Board Committee, the authority of the Board of Directors in the management of the corporation as may be deemed by the Executive Committee to be appropriate, to be exercised in time periods between regularly scheduled meetings of the Board of Directors provided that the Executive Committee has the authority to act only in time sensitive or emergency situations. The Director and the Executive Director of the corporation serve as ex officio members of the Executive Committee without voting rights. The Executive Committee does not have the authority to amend, alter or repeal the bylaws elect, appoint or remove any member of such Executive Committee or any director or officer of the corporation amend the articles of incorporation adopt a plan of merger or adopt a plan of consolidation with another corporation authorize the sale, lease or exchange of all or substantially all the property and assets of the corporation not in the ordinary course of business authorize the voluntary dissolution of the corporation or revoke proceedings therefore adopt a plan for the distribution of the assets of the corporation or amend, alter or repeal any resolution of the Board which by its terms provides that it shall not be amended, altered or repealed by such Executive Committee. The Executive Committee also serves as the planning committee for the Board of Directors and oversees any compliance issues raised by the Board of Directors.
Form 990, Part VI, Section A, Line 6, 7	Virginia Mason Health System VMHS is the sole corporate member of Benaroya Research Institute at Virginia Mason BRI. VMHS as the sole voting member has the following approval rights a election or appointment of Directors and Officers of the Board of Directors b removal of Directors and Officers of the Board of Directors including any executive officer of the corporation c approval of all long-range and short-range plans proposed by the Board of Directors d approval of the annual capital and operating budgets proposed by the Board of Directors e approval of the borrowing of funds where the amount borrowed is in excess of Five Hundred Thousand Dollars 500,000 f approval of the sale, lease, exchange, mortgage, pledge or disposal of all or substantially all of the property and assets g approval of all amendments to or repeal of the Agreement Association or the Bylaws of the corporation h all other rights and powers as specified in the Washington Nonprofit Corporation Act.
Form 990, Part VI, Section B, Line 11b	The Virginia Mason Health System Audit and Compliance Committee ACC, a committee composed of independent community members has been delegated responsibility for oversight of the annual Form 990 preparation process including a selection, engagement, and review of the performance of the independent tax preparer b review of the annual draft Form 990 tax return, and c recommendation of the final Form 990 tax return for review to the BRI Board of Directors. Annually, at the September meeting, management and the tax preparer provides the ACC with an initial draft of the Form 990 and present an overview of the Form 990 preparation process. The final draft Form 990 is reviewed and approved by the ACC in November followed by a Board review of the final Form 990 prior to filing. The final Form 990 tax return is provided to each member of the Board of Directors via electronic delivery.
Form 990, Part VI, Section B, Line 12c	The Virginia Mason Health System Governance Committee has been delegated accountability for oversight of the process for disclosure, evaluation and management of conflict of interest involving any member of the Benaroya Research Institute at Virginia Mason BRI Board of Directors, executive leadership or key employees Covered Person. Pursuant to the Conflict of Interest Policy, an annual conflict of interest questionnaire is distributed to all Covered Persons. In addition, a Covered Person has an on-going duty to disclose the existence of a conflict of interest at any time an actual or potential conflict arises. Each Covered Person is required upon appointment and annually thereafter to attest to a statement that affirms that such person has a received a copy of the Conflict of Interest Policy b has read and understands the Policy c has agreed to comply with the Policy and d understands that BRI is a charitable organization and that in order to maintain its federal tax exemption must engage in activities that accomplish its tax-exempt purposes. Written disclosures are reviewed by the Governance Committee to determine if an actual or potential conflict of interest exists and if so, how it should be managed. The Covered Person is informed in writing regarding the determination the Conflict of Interest Management Plan. No Covered Person with an actual or potential conflict of interest shall engage in an activity on BRIs behalf related to the disclosed actual or potential Conflict of Interest unless such activity is permitted by the Conflict of Interest Management Plan or until the Covered Person has undertaken all steps set forth in the Management Plan to manage, reduce or eliminate the conflict. All Covered Persons have a duty to disclose the existence of any actual or potential conflict of interest with respect to meeting agenda items. The Conflict of Interest Policy requires that copies of the Conflict of Interest Questionnaire be completed annually by each Covered Person and any Conflict of Interest Management Plan be maintained.
Form 990, Part VI, Section B, Line 15	The VMHS Compensation and Benefits Board Committee, a committee composed solely of independent directors none of whom have a conflict of interest, is accountable for setting reasonable total compensation packages for each executive, officer and key employee Executive consistent with BRIs compensation philosophy and principles. The Committee approves annual goals and performance criteria which are used in determining merit increases and variable compensation opportunities. The Committee assesses performance against these goals. The Committee selects and engages a qualified independent compensation consultant to review and analyze the total compensation and benefits packages of the Executives. The Committee as part of its analysis obtains from the compensation consultant appropriate comparability data including total compensation paid by similarly situated organizations for positions that are functionally comparable to each of the Executives. The Committee will consider the significant terms of the agreement with each Executive including the total compensation to be paid and the employees duties and responsibilities. Consistent with the compensation philosophy and principles, the Committee approves total compensation packages for each of the Executives based on information presented to the Committee, reasonableness and the best interest of BRI. The Committees decisions regarding compensation for each Executive are documented in written resolutions and minutes of the Committee. The Committee promptly reports its actions to the VMHS board which reports are reflected in the Boards minutes. The individual positions who were reviewed in 2018 were Jane Buckner, BRI President and Director, Carla Greenbaum, BRI Director, and Homer Lane, Executive Director and Chief Financial Officer.
Form 990, Part VI, Section C, Line 19	The organizations Articles, Bylaws, Conflict of Interest Policy and financial statements are made available upon request.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (5 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Direct Controlling NADirectControllingNACd	Controlled OrganizationControlledOrganizationInd	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
Virginia Mason Health System
1100 Ninth Avenue	Seattle	WA	98101	911351110	Fundraising	WA	Sec 501c3	7	N/A	Yes (true)
Virginia Mason Medical Center
1100 Ninth Avenue	Seattle	WA	98101	910565539	Health Care	WA	Sec 501c3	3		false	VMHS
Virginia Mason Institute
1100 Ninth Avenue	Seattle	WA	98101	263763656	Education	WA	Sec 501c3	9		false	VMMC
Yakima Valley Memorial Hospital Association
2811 Tieton Drive	Yakima	WA	98902	910567263	Health Care	WA	Sec 501c3	3		false	VMHS
Children's Village
3801 Kern Rd	Yakima	WA	98902	352654720	Supporting Organization	WA	Sec 501c3	12	N/A	false

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	Yes (true)	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	Yes (true)	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	false	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (true)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (true)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd

Affiliated Group Schedule AffiliatedGroupSchedule

Affiliated Schedule AffiliatedScheduleGrp (5 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Total Grassroots LobbyTotalGrassrootsLobbyAmt	Total Direct LobbyTotalDirectLobbyAmt	Total Lobby ExpenditureTotalLobbyExpenditureAmt	Other Exempt Purpose ExpendOtherExemptPurposeExpendAmt	Total Exempt Purpose ExpendTotalExemptPurposeExpendAmt	Lobby NontxLobbyNontxAmt	Grassroots NontxGrassrootsNontxAmt	Total Lobby Grssroot Mns NontxTotalLobbyGrssrootMnsNontxAmt	Tot Lbby Expend Mns Lobby NontxTotLbbyExpendMnsLobbyNontxAmt	Share Excess Lobby ExpendShareExcessLobbyExpendAmt	Electing OrganizationElectingOrganizationInd
Benaroya Research Institute at Virginia Mason
1201 Ninth Avenue	Seattle	WA	98101	910653422	$0	$0	$0	$66,780,571	$66,780,571	$39,612	$9,903	$0	$0	$0
Virginia Mason Health System
1100 Ninth Avenue	Seattle	WA	98101	911351110	$0	$0	$0	$24,630,107	$24,630,107	$14,610	$3,653	$0	$0	$0
Virginia Mason Medical Center
1100 Ninth Avenue	Seattle	WA	98101	910566539	$133,835	$53,574	$187,409	$1,108,735,210	$1,108,922,619	$657,772	$164,443	$0	$0	$0	Yes (X)
Virginia Mason Institute
1100 Ninth Avenue	Seattle	WA	98101	263763856	$0	$0	$0	$6,889,011	$6,889,011	$4,086	$1,022	$0	$0	$0
Yakima Vallley Memorial Hospital Association
2811 Tieton Drive	Yakima	WA	98902	910567263	$46,629	$60,000	$106,629	$478,546,936	$478,653,565	$283,920	$70,980	$0	$0	$0